Hepatocellular carcinoma in the United States. Prognostic features, treatment outcome, and survival.
about
Pretreatment serum albumin as a predictor of cancer survival: a systematic review of the epidemiological literatureAre metastases from metastases clinical relevant? Computer modelling of cancer spread in a case of hepatocellular carcinoma.Adjuvant percutaneous radiofrequency ablation of feeding artery of hepatocellular carcinoma before treatment.Comparison of coplanar and noncoplanar intensity-modulated radiation therapy and helical tomotherapy for hepatocellular carcinoma.High incidence of hepatitis B infection-associated cirrhosis and hepatocellular carcinoma in the Southeast Asian patients with portal vein thrombosis.Epidemiology and survival of patients with hepatocellular carcinoma in Southern Germany.Integrated metabolomic profiling of hepatocellular carcinoma in hepatitis C cirrhosis through GC/MS and UPLC/MS-MS.An analysis of 412 cases of hepatocellular carcinoma at a Western center.Review of 336 patients with hepatocellular carcinoma at Songklanagarind HospitalNon-surgical treatment of hepatocellular carcinoma.Transcatheter arterial chemoembolization combined with radiofrequency ablation delays tumor progression and prolongs overall survival in patients with intermediate (BCLC B) hepatocellular carcinoma.A new model to estimate prognosis in patients with hepatocellular carcinoma after Yttrium-90 radioembolization.Complications of loco-regional therapy in the liver-spectrum of imaging findings by CT and MRIClinical presentation of hepatocellular carcinoma (HCC) in Asian-Americans versus non-Asian-AmericansHepatocellular carcinoma in Central Europe: prognostic features and survival.Clinicopathological characteristics of alpha-fetoprotein-producing gastric cancer.Indications for referral and assessment in adult liver transplantation: a clinical guideline. British Society of Gastroenterology.Staging of hepatocellular carcinoma: assessment of the CLIP, Okuda, and Child-Pugh staging systems in a cohort of 257 patients in Toronto.Wnt signaling in liver cancer.A Collision Probability Model of Portal Vein Tumor Thrombus Formation in Hepatocellular Carcinoma.Refusal of cancer-directed surgery strongly impairs survival of patients with localized hepatocellular carcinoma.Hepatocellular Carcinoma Without Cirrhosis Presenting With Hypercalcemia: Case Report and Literature Review.Metastatic hepatocellular carcinoma presenting as facial nerve palsy and facial pain.Analysis of prognostic factors and 5-year survival rate in patients with hepatocellular carcinoma: a single-center experience.Radiation therapy for portal venous invasion by hepatocellular carcinoma.Hypofractionated radiotheapy using helical tomotherapy for advanced hepatocellular carcinoma with portal vein tumor thrombosis.Emergency endoscopic variceal ligation following variceal rupture in patients with advanced hepatocellular carcinoma and portal vein tumor thrombosis: a retrospective study.Survival rate in patients with hepatocellular carcinoma: a retrospective analysis of 389 patientsPredictors of alcohol use among rural drug users after disclosure of hepatitis C virus status.Incidence, risk factors and consequences of portal vein and systemic thromboses in hepatocellular carcinoma.Liver transplantation for hepatocellular carcinoma in Ireland: Pre-operative alpha-fetoprotein predicts tumour recurrence in a 14-year single-centre national experience.Clinical outcome in patients with hepatocellular carcinoma after living-donor liver transplantation.Preoperative alpha-fetoprotein slope is predictive of hepatocellular carcinoma recurrence after liver transplantationMeta-analysis: underutilisation and disparities of treatment among patients with hepatocellular carcinoma in the United States.Highly metabolic thrombus of the portal vein: 18F fluorodeoxyglucose positron emission tomography/computer tomography demonstration and clinical significance in hepatocellular carcinomaThe response of thrombosis in the portal vein or hepatic vein in hepatocellular carcinoma to radiation therapy.Practical effect of sorafenib monotherapy on advanced hepatocellular carcinoma and portal vein tumor thrombosisCharacteristic analysis of α-fetoprotein-producing gastric carcinoma in China.The antitumor effect and hepatotoxicity of a hexokinase II inhibitor 3-bromopyruvate: in vivo investigation of intraarterial administration in a rabbit VX2 hepatoma model.Radiofrequency ablation following first-line transarterial chemoembolization for patients with unresectable hepatocellular carcinoma beyond the Milan criteria.
P2860
Q24601580-4318EED1-04F9-47FF-9D16-45DBB8358AE2Q31060250-C9FDF8B8-8226-4089-9B1A-4D26BE93D7AAQ33460537-22DA0589-ABB0-43E0-AA61-EC41496442DBQ33894890-22C2F40F-DA65-407A-9836-A050E2E7480BQ33928227-93110997-584D-4FC6-88B2-E65FAA6CE442Q33951214-49F740E8-1468-4E31-B5DA-1832710D68A2Q34214476-7C314198-C0AE-47C7-95DE-F3D162B8BAC2Q34503813-5BDBEDF6-A686-429B-BA60-237A6C7EA368Q34511976-8BC68BCA-67FF-47FC-95A7-9BF520AC86BDQ34539241-CCBEBC2C-652A-42DF-ADA8-77095B5B10B2Q34636766-59DC3BFA-A4A1-465F-AAD6-5BA0E05AE237Q35075280-0563B5AD-ADC4-4E76-82CE-09E91C1FFA11Q35095935-168C6819-A1AB-40C1-B160-726ED2ACDA99Q35163337-A9181F86-0D35-4C6E-BC00-F50D2F8121DCQ35362361-3CD47678-E3FC-4A19-8DDE-D10B1D811A8FQ35480948-132985E5-79CE-4D33-840A-1A6C0DB55867Q35579265-AB92FE3B-C9F5-4C06-9C6F-A3EB3B95399CQ35594697-00EBE8B2-06D5-48C7-ABCA-88B95DD242C2Q35659072-D109021D-2916-4231-B03E-2A971DB69A4DQ35679594-845CCA81-8727-4F8B-B7BD-EED05DC50F69Q35692190-B04660D6-04FF-4743-8694-A52880F85AE0Q35818322-72F94061-4324-4297-BDBF-470344FE20D5Q35833206-49CC0102-10EF-4A25-B2B0-D77E6072AACFQ35890624-C80E8FF4-FE59-47D7-8497-FD7D699851AFQ36497043-4FC24B69-3DDE-41F5-A47B-433779466279Q36604392-591E62E4-D5EB-4ECC-8A46-99E3DDE4E7E6Q36612038-00E0B18A-337B-4D42-91CE-9ECB038DB548Q36615885-FE5F7776-AE60-4B3F-8838-F239A21897B2Q36698904-BCAFE910-1B8C-478B-A518-3520BA8F754EQ36812718-73B3A79A-B228-4BFD-99B5-BF7AADE07138Q37035208-F7D3D570-E14C-4B74-AF97-AB18DE0144A3Q37068256-D673271D-DC6F-4FFB-B440-F88F4671A55BQ37130713-7BBBED0E-9498-44C2-908E-FCD2E09BC7EDQ37184472-67EBDD41-AD68-4701-A81C-F05C69A59772Q37212938-89241FC8-9126-4BBC-8CCF-353450146A17Q37343470-5F5DC8AA-F648-4291-8726-575CAA287983Q37359379-8DAD69EE-AEF9-4DE0-B720-0506610ECE15Q37362382-3CFF414E-D99A-43DA-B0B1-66ACE5CD774FQ37406500-8E583E08-EA13-4131-AD22-25DBB3502EE5Q37474142-8290B51C-67C2-40B8-AF2B-50D24825F869
P2860
Hepatocellular carcinoma in the United States. Prognostic features, treatment outcome, and survival.
description
1996 nî lūn-bûn
@nan
1996年の論文
@ja
1996年学术文章
@wuu
1996年学术文章
@zh
1996年学术文章
@zh-cn
1996年学术文章
@zh-hans
1996年学术文章
@zh-my
1996年学术文章
@zh-sg
1996年學術文章
@yue
1996年學術文章
@zh-hant
name
Hepatocellular carcinoma in th ...... eatment outcome, and survival.
@en
Hepatocellular carcinoma in th ...... eatment outcome, and survival.
@nl
type
label
Hepatocellular carcinoma in th ...... eatment outcome, and survival.
@en
Hepatocellular carcinoma in th ...... eatment outcome, and survival.
@nl
prefLabel
Hepatocellular carcinoma in th ...... eatment outcome, and survival.
@en
Hepatocellular carcinoma in th ...... eatment outcome, and survival.
@nl
P2093
P1433
P1476
Hepatocellular carcinoma in th ...... eatment outcome, and survival.
@en
P2093
P304
P356
10.1002/(SICI)1097-0142(19960601)77:11<2217::AID-CNCR6>3.3.CO;2-P
P407
P577
1996-06-01T00:00:00Z